Sartorius Stedim BioOutsource

Sartorius Stedim BioOutsource is a provider of contract testing services to the biopharmaceutical and biotechnology industries, offering an extensive range of services to support bioanalytical testing and biosafety contract testing of biologic drugs and vaccines.

TypeSubsidiary
Parent CompanySartorius Stedim Biotech
HQGlasgow, GB
Founded2007
Websitebiooutsource.com
Cybersecurity ratingAMore
Sartorius Stedim BioOutsource was founded in 2007 and is headquartered in Glasgow, GB

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Sartorius Stedim BioOutsource

Hugo de Wit

Hugo de Wit

Managing Director
Gillian Hill

Gillian Hill

Director of Operations
Mitch Scanlan

Mitch Scanlan

Director Sales & Marketing
Show more

Sartorius Stedim BioOutsource Office Locations

Sartorius Stedim BioOutsource has an office in Glasgow
Glasgow, GB (HQ)
1 Technology Terrace, Todd Campus, West of Scotland Science Park
Show all (1)

Sartorius Stedim BioOutsource Financials and Metrics

Summary Metrics

Founding Date

2007
Sartorius Stedim BioOutsource is a subsidiary of Sartorius Stedim Biotech

Sartorius Stedim BioOutsource Revenue

Embed Graph
View revenue for all periods
Sartorius Stedim BioOutsource's revenue was reported to be £8.96 m in FY, 2018
GBPFY, 2014FY, 2016FY, 2017FY, 2018

Revenue

5.5m13.1m10.9m9.0m

Cost of goods sold

2.5m5.1m7.1m7.2m

Gross profit

3.0m8.0m3.8m1.7m

Gross profit Margin, %

54%61%35%19%
GBPFY, 2014FY, 2016FY, 2017FY, 2018

Cash

651.0k1.3m708.3k

Accounts Receivable

1.2m2.2m2.3m2.0m

Inventories

483.4k593.4k627.2k722.7k

Current Assets

2.4m5.0m4.3m3.7m
GBPFY, 2014

Financial Leverage

2 x
Show all financial metrics

Sartorius Stedim BioOutsource Cybersecurity Score

Cybersecurity ratingPremium dataset

A

98/100

SecurityScorecard logo

Sartorius Stedim BioOutsource Online and Social Media Presence

Embed Graph

Sartorius Stedim BioOutsource Blogs

Cell Status Monitoring using a Real Time Cell Analyser (label free)

The RTCA MP instrument (ACEA Biosciences, Agilent) is designed for label-free cell based assays. A microelectronic biosensor array is incorporated into each well of the 96 well microplate, allowing the RTCA MP (multiple plate) (Figure 1) instrument to measure the activity of living cells in real-tim…

Making assays faster: Single use frozen cells prepared in house decrease assay turnaround while increasing flexibility

Bioassays are reliant on the use of either primary cells or cultured cell lines depending on the assay format. Cultured cells offer increased flexibility over primary cells and so are widely used as a substitute to primary cell lines where appropriate. The immortalisation of continuously cultured ce…

How to characterise omalizumab

Immunoglobulin E (IgE) functions to recognise the presence of foreign particles, and in combination with mast cells, form part of the adaptive immune response in charge of mounting powerful inflammatory reactions. Under normal circumstances, IgE forms a very small proportion of circulating immunoglo…

Improved Characterization of IgG2 isoforms by LC-MS

The majority of therapeutic mAbs developed so far belong to the IgG1 subclass, although some are IgG2 or IgG4. These different IgG subclasses differ in terms of the connectivity of their disulfide bonds. Whereas IgG1 molecules generally only have one defined structure, IgG2 antibodies can exist as t…

Comparative Assessment of mAb C1q Binding Using a Sensitive SPR Assay

Developing a Method for a Complex Molecular Interaction Effector functions such as complement dependent cytotoxicity (CDC) are important modes of action for many therapeutic monoclonal antibodies (mAbs). The degree of C1q binding and resultant CDC activity can influence the safety and efficacy of a …

What is Mycoplasma?

Mycoplasmas are the smallest self-replicating organisms currently known to science. Common in nature, they are a group of simple bacteria characterized by a lack of a cell wall and a small genome. Many Mycoplasma species are found in the respiratory tracts of animals, where they have been associated…
Show more

Sartorius Stedim BioOutsource Frequently Asked Questions

  • When was Sartorius Stedim BioOutsource founded?

    Sartorius Stedim BioOutsource was founded in 2007.

  • Who are Sartorius Stedim BioOutsource key executives?

    Sartorius Stedim BioOutsource's key executives are Hugo de Wit, Gillian Hill and Mitch Scanlan.

  • How many employees does Sartorius Stedim BioOutsource have?

    Sartorius Stedim BioOutsource has 136 employees.

  • What is Sartorius Stedim BioOutsource revenue?

    Latest Sartorius Stedim BioOutsource annual revenue is £9 m.

  • What is Sartorius Stedim BioOutsource revenue per employee?

    Latest Sartorius Stedim BioOutsource revenue per employee is £65.9 k.

  • Who are Sartorius Stedim BioOutsource competitors?

    Competitors of Sartorius Stedim BioOutsource include Advarra, Biogen and MyoKardia.

  • Where is Sartorius Stedim BioOutsource headquarters?

    Sartorius Stedim BioOutsource headquarters is located at 1 Technology Terrace, Todd Campus, West of Scotland Science Park, Glasgow.

  • Where are Sartorius Stedim BioOutsource offices?

    Sartorius Stedim BioOutsource has an office in Glasgow.

  • How many offices does Sartorius Stedim BioOutsource have?

    Sartorius Stedim BioOutsource has 1 office.